Search clinical trials for: GLP-1 Receptor Agonists
Total 64845 results
-
University of BathArla FoodsCompletedGLP-1 ConcentrationUnited Kingdom
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedGut Microbiota | GLP-1Mexico
-
Adrian VellaCompletedPancreatic Effects of 9,39-Exendin and 9,36-GLP-1United States
-
Rigshospitalet, DenmarkDepartment of Cardiovascular and Renal Research, University of Southern DenmarkCompleted
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Merck Sharp & Dohme LLCCompletedHyperglycemiaGermany
-
Zealand PharmaCompleted
-
Indonesia UniversityDr Cipto Mangunkusumo General Hospital; SEAMEO Regional Centre for Food and...CompletedObesity | Ghrelin | Appetite | Gut Hormones | PYY | VAS of Satiety | VAS of Hunger | GLP - 1Indonesia
-
Third Military Medical UniversityUnknownGLP-1；Metformin；Telomere-telomerase System；Par-4China
-
Hvidovre University HospitalUnknown
-
University of CopenhagenGentofte Hospital, DenmarkRecruiting
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknownThe Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration.Denmark
-
Medical University of South CarolinaCompletedDiabetes | Glucagon-like Peptide 1 | GLP-1 | Gastric Content AspirationUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2India
-
Radboud University Medical CenterTurku University Hospital; Charite University, Berlin, Germany; University Medical... and other collaboratorsUnknown
-
University of Mississippi Medical CenterRecruitingDiabetes Mellitus, Type 2 | Osteoporosis, PostmenopausalUnited States
-
Dasman Diabetes InstituteRecruitingDiabetes Mellitus, Type 2Kuwait
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Romania, Russian Federation, Germany, Netherlands, Turkey, Bulgaria, India, Taiwan, Czech Republic, Tunisia, Japan, Egypt, Israel, Korea, Republic of, Thailand
-
Anders Fink-Jensen, MD, DMSciRecruitingSchizophrenia | Type 2 Diabetes | Metabolic Disturbance | Clozapine | Olanzapine | GLP-1Denmark
-
University of CopenhagenCompleted
-
Zealand PharmaProfil Institut für Stoffwechselforschung GmbHRecruitingSafety and TolerabilityGermany
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Romania, Ukraine, Germany, Italy, Estonia, Malaysia, Philippines, Mexico, Lithuania, Colombia, Slovakia, Chile
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Poland, Romania, Russian Federation, Ukraine, India, Belgium, Mexico, Tunisia, Japan, Israel, Korea, Republic of
-
University of PadovaAzienda Ospedaliera di PadovaUnknown
-
Sapporo Medical UniversityMerck Sharp & Dohme LLCCompletedCoronary Artery DiseaseJapan
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
Radboud University Medical CenterCompletedType 1 DiabetesNetherlands
-
University of ChicagoCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Karl NeffUniversity College DublinCompletedDiabetic Kidney DiseaseIreland
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Canada, Romania, Russian Federation, Ukraine, Germany, Spain, Philippines, Czech Republic, Mexico, Croatia, Chile, Morocco, South Africa, Australia, Venezuela
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
University of PennsylvaniaCompleted
-
University of Missouri-ColumbiaAmerican Society for Metabolic and Bariatric SurgeryRecruitingHypertension | Diabetes Mellitus | Metabolic Syndrome | Morbid Obesity | Obstructive Sleep Apnea of AdultUnited States
-
SanofiCompleted
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
SanofiCompletedDiabetes Mellitus Type 2United States, Austria, Canada, France, Germany, Greece, Guatemala, India, Mexico, Peru, Puerto Rico, Romania, Turkey
-
University Health Network, TorontoNovo Nordisk A/SWithdrawnPsoriasis | Type 2 Diabetes | Impaired Glucose Tolerance | Psoriatic ArthritisCanada
-
Nicolai Jacob Wewer AlbrechtsenCompleted
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
Shanghai 10th People's HospitalUnknown
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Zoltan PatakyUniversity of Geneva, SwitzerlandCompleted
-
Astellas Pharma IncCompleted
-
Peking Union Medical College HospitalUnknownPolycystic Ovary SyndromeChina
-
King's College LondonRecruitingObesity | Diabetes Mellitus | Mental Health IssueUnited Kingdom
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...CompletedDiabetes Mellitus, Type 2Italy
-
National Institute on Drug Abuse (NIDA)Recruiting